Daihan Pharmaceutical Co.Ltd (023910.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea · ISIN KR7023910003
Price
24,800.00 KRW
Market cap
145.82 bn KRW
P/E (2025)
5.28
P/S (2025)
0.70
Dividend yield
4.03 %
Net margin
13.25 %
Return on equity (ROE)
9.21 %
Return on assets (ROA)
7.95 %
Daihan Pharmaceutical Co.Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 204.19 bn KRW | 208.61 bn KRW |
| Gross profit | 69.79 bn KRW | 64.82 bn KRW |
| Operating income | 38.03 bn KRW | 31.19 bn KRW |
| EBIT | 42.33 bn KRW | 33.16 bn KRW |
| Net income | 33.76 bn KRW | 27.64 bn KRW |
| Diluted EPS – continuing operations | 5,741.34 KRW | 4,701.33 KRW |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Daihan Pharmaceutical Co.Ltd
Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea.
More stocks
- AMPAK Technology Inc. (6546.TWO)
- Bank of South Carolina Corp (BKSC)
- Decisive Dividend Corp (DE.V)
- S-Tech Corp. (1584.TWO)
- Neuronetics, Inc. (STIM)
- University Bancorp Inc (UNIB)
- Rafael Microelectronics (6568.TWO)
- Fortitude Gold Corp (FTCO)
- DMS Co.Ltd (068790.KQ)
- Vytrus Biotech S.A. (VYT.MC)
- Au Brandz Co.,Ltd (481070.KQ)
- Julong Holding Limited Class A Ordinary Shares (JLHL)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.